To provide insights on European health priorities for 2022 and how AmCham EU and others can work together in the future, Andrea Chiarello, Chair, Healthcare Committee, AmCham EU joined AmCham Belgium for a roundtable discussion on Monday, 14 February. The panellists touched on the state of play of key EU developments in pharmaceuticals, medical devices and broader life sciences policy. It was also highlighted that strong collaboration between AmCham EU and AmCham Belgium could strengthen an innovation-driven agenda for life sciences.
Healthcare roundtable: designing EU's innovation-driven agenda
To provide insights on European health priorities for 2022 and how AmCham EU and others can work together in the future, Andrea Chiarello, Chair, Healthcare Committee, AmCham EU joined AmCham Belgium for a roundtable discussion on Monday, 14 February. The panellists touched on the state of play of key EU developments in pharmaceuticals, medical devices and broader life sciences policy. It was also highlighted that strong collaboration between AmCham EU and AmCham Belgium could strengthen an innovation-driven agenda for life sciences.
Related items
:focal())
News
20 May 2026
Healthcare, competitiveness, innovation and simplification
Europe’s life sciences sector sits at the heart of the EU’s competitiveness agenda. It supports advanced manufacturing and helps bring new treatments and technologies to patients. Yet companies deciding where to invest need a regulatory environment that is predictable and open to global cooperation.
The European Commission’s work on the Biotech Act and the targeted revision of the Medical Devices and In Vitro Diagnostics Regulations (MDR/IVDR) offers an opportunity to improve that environment. Both files can help make Europe a stronger location for life sciences investment.
The EU should use this moment to build a framework that keeps pace with scientific progress. That means faster and clearer procedures. It also means better use of data and intellectual property rules that recognise the realities of global supply chains.
:focal())
Position Paper
19 May 2026
Strengthening EU competitiveness through an adaptive MDR/IVDR framework
Position Paper
19 May 2026
A global approach to strengthening Europe’s biotechnology ecosystem
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.